Author

Ho Kyun Yoo

Observed name: Hokyun Yoo

Institution: Daewoong Pharmaceutical (South Korea)

Observed institution: Daewoong Pharmaceutical (South Korea)

ORCID: 0000-0003-1804-280X

Observed ORCID: 0000-0003-1804-280X

OpenAlex ID: A5124715620

Pharmacodynamic and Pharmacokinetic Drug Interactions between Fexuprazan, a Novel Potassium-Competitive Inhibitor, and Aspirin, in Healthy Subjects

2023 · JungJin Oh, Eunsol Yang, et al. · Pharmaceutics · 10

Efficacy and safety of a novel sodium picosulfate oral tablet in a randomized controlled trial for bowel preparation

2026 · Su Bum Park, Sang Bum Kang, et al. · World Journal of Gastroenterology · 2

Tu1202 EFFICACY AND SAFETY OF 14-DAY FEXUPRAZAN-BASED TRIPLE THERAPY FOR FIRST-LINE TREATMENT OF HELICOBACTER PYLORI INFECTION: A RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED TRIAL

2026 · Byung-Hoon Min, Gwang Ho Baik, et al. · Gastroenterology · 1

Tu1202 EFFICACY AND SAFETY OF 14-DAY FEXUPRAZAN-BASED TRIPLE THERAPY FOR FIRST-LINE TREATMENT OF HELICOBACTER PYLORI INFECTION: A RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED TRIAL

2026 · Byung-Hoon Min, Gwang Ho Baik, et al. · Gastrointestinal Endoscopy

Works count: 4

Citation count: 13

H-index: 2

I10-index: 1